Theralase Technologies
Stock Forecast, Prediction & Price Target
Theralase Technologies Financial Estimates
Theralase Technologies Revenue Estimates
Theralase Technologies EBITDA Estimates
Theralase Technologies Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CA$780.64K N/A | CA$1.13M 45.85% | CA$1.07M -5.99% | Avg: CA$2.09M Low: CA$2.09M High: CA$2.09M avg. 95.35% | Avg: CA$34.76M Low: CA$34.76M High: CA$34.76M avg. 1562.68% | Avg: CA$75.53M Low: CA$75.53M High: CA$75.53M avg. 117.28% | Avg: CA$116.44M Low: CA$116.44M High: CA$116.44M avg. 54.15% |
Net Income
% change YoY
| CA$-4.41M N/A | CA$-5.24M -18.84% | CA$-4.57M 12.91% | Avg: CA$-2.19M Low: CA$-2.19M High: CA$-2.19M avg. 51.87% | Avg: CA$4.39M Low: CA$4.39M High: CA$4.39M avg. 300.00% | Avg: CA$13.19M Low: CA$13.19M High: CA$13.19M avg. 200.00% | Avg: CA$21.99M Low: CA$21.99M High: CA$21.99M avg. 66.66% |
EBITDA
% change YoY
| CA$-4.24M N/A | CA$-4.88M -15.20% | CA$-4.25M 12.95% | Avg: CA$-2.09M Low: CA$-2.09M High: CA$-2.09M avg. 50.85% | Avg: CA$-34.76M Low: CA$-34.76M High: CA$-34.76M avg. -1562.68% | Avg: CA$-75.53M Low: CA$-75.53M High: CA$-75.53M avg. -117.28% | Avg: CA$-116.44M Low: CA$-116.44M High: CA$-116.44M avg. -54.15% |
EPS
% change YoY
| -$0.02 N/A | -$0.03 -16.66% | -$0.02 17.46% | Avg: -$0.01 Low: -$0.01 High: -$0.01 avg. 51.92% | Avg: $0.02 Low: $0.02 High: $0.02 avg. 300% | Avg: $0.06 Low: $0.06 High: $0.06 avg. 199.99% | Avg: $0.1 Low: $0.1 High: $0.1 avg. 66.66% |
Operating Expenses
% change YoY
| CA$4.85M N/A | CA$5.85M 20.78% | CA$5.15M -12.07% | Avg: CA$4.90M Low: CA$4.90M High: CA$4.90M avg. -4.82% | Avg: CA$81.53M Low: CA$81.53M High: CA$81.53M avg. 1562.68% | Avg: CA$177.15M Low: CA$177.15M High: CA$177.15M avg. 117.28% | Avg: CA$273.09M Low: CA$273.09M High: CA$273.09M avg. 54.15% |
FAQ
What is Theralase Technologies stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 154.63% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -2.19M, average is -2.19M and high is -2.19M.
What is Theralase Technologies stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 457.36% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is CA$2.09M, average is CA$2.09M and high is CA$2.09M.
What is Theralase Technologies stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 154.64% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.01, average is -$0.01 and high is CA$-0.01.